Dose Optimization of MDMA-Assisted Therapy for PTSD

Summary

This open label, within-subjects dose optimization trial will investigate the optimal number of MDMA-Assisted Therapy treatment cycles (i.e., one MDMA session and three integration sessions) in a sample of U.S. veterans with PTSD. Participants will complete from one to five cycles of MDMA-AT.

Timeline

Start

2025-06-03

Primary completion

2029-10

Completion

2029-10

Drugs

Indications